University of Kansas Cancer Center

Site:	University of Kansas Cancer Center
Address:	12200 West 110th Street,
City:	Overland Park
State:	KS
Zip:	66210
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy (StrateGIST 3)	Recruiting	Active	IDRX-42	NCT07218926